← Back to Search

Diagnostic Arthroscopy using the Arthrex NanoScope for Wrist arthritis

N/A
Waitlist Available
Led By Nader Paksima
Research Sponsored by NYU Langone Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up day 1
Awards & highlights
No Placebo-Only Group

Summary

This trial tests the Arthrex NanoScope, a small camera used in wrist surgeries, on patients with wrist issues. The camera helps doctors see inside the wrist joint to diagnose problems and decide on treatments.

Eligible Conditions
  • Wrist arthritis

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~day 1
This trial's timeline: 3 weeks for screening, Varies for treatment, and day 1 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Surgeon-Rated Midcarpal Visualization With Arthrex Nanoscope
Surgeon-Rated Midcarpal Visualization With Conventional Instrument
Surgeon-Rated Radiocarpal Visualization With Arthrex Nanoscope
+1 more
Secondary study objectives
Surgeon-rated Confidence in Arthrex NanoScope Diagnosis
Surgeon-rated Confidence in Conventional Instrument Diagnosis
Surgeon-rated Ease of Use of Arthrex NanoScope
+1 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Experimental CohortExperimental Treatment2 Interventions
Patients with clinically diagnosed wrist pathology undergoing wrist arthroscopy
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Diagnostic Arthroscopy using the Arthrex NanoScope
2020
N/A
~20
Diagnostic Arthroscopy using standard arthroscopic instruments
2020
N/A
~20

Find a Location

Who is running the clinical trial?

NYU Langone HealthLead Sponsor
1,408 Previous Clinical Trials
855,765 Total Patients Enrolled
Nader PaksimaPrincipal InvestigatorNYU Langone Health
1 Previous Clinical Trials
23 Total Patients Enrolled
~4 spots leftby Nov 2025